Zhang, M., Yang, L., Hou, L., & Tang, X. (2021). LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer. Taylor & Francis Group.
Cita Chicago Style (17a ed.)Zhang, Mingkun, Liu Yang, Lan Hou, y Xueyuan Tang. LncRNA SNHG1 Promotes Tumor Progression and Cisplatin Resistance Through Epigenetically Silencing MiR-381 in Breast Cancer. Taylor & Francis Group, 2021.
Cita MLA (8a ed.)Zhang, Mingkun, et al. LncRNA SNHG1 Promotes Tumor Progression and Cisplatin Resistance Through Epigenetically Silencing MiR-381 in Breast Cancer. Taylor & Francis Group, 2021.
Precaución: Estas citas no son 100% exactas.